Almirall, S.A. (BME:ALM)
Spain · Delayed Price · Currency is EUR 10.18
+0.08 (0.79%)
Oct 6, 2026, 5:35 PM CET
Almirall Market Cap
Almirall has a market cap or net worth of €2.22 billion as of October 6, 2026. Its market cap has decreased by -13.55% in one year.
Market Cap
2.22B
Enterprise Value
2.23B
Revenue
1.16B
Ranking
n/a
PE Ratio
36.55
Stock Price
€10.18
ChartMarket Cap Chart
Since June 20, 2007, Almirall's market cap has decreased from 2.37B to 2.22B, a decrease of -6.52%. That is a compound annual growth rate of -0.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 2.22B | -19.61% |
| Dec 31, 2025 | 2.76B | 56.88% |
| Dec 31, 2024 | 1.76B | -0.35% |
| Dec 29, 2023 | 1.76B | 7.51% |
| Dec 30, 2022 | 1.64B | -19.23% |
| Dec 30, 2021 | 2.03B | 4.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.79B |
| Laboratorios Farmaceuticos Rovi | 2.92B |
| Faes Farma | 1.44B |
| Pharma Mar | 1.22B |
| Clínica Baviera | 885.03M |
| Oryzon Genomics | 222.77M |
| Prim, S.A. | 215.15M |
| Laboratorio Reig Jofre | 215.04M |